http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101929973-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
filingDate | 2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101929973-B1 |
titleOfInvention | Trisaccharide derivates, and their use as adjuvants |
abstract | The present invention relates to the use of a trisaccharide core completely substituted with a fatty acid ester group and optionally a trisaccharide derivative comprising at least one anion group, such a trisaccharide derivative, a process for the preparation of such a trisaccharide derivative, An obtained trisaccharide, an adjuvant composition comprising such a trisaccharide derivative, and a vaccine or kit comprising such adjuvants. |
priorityDate | 2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.